Last Posted: Oct 09, 2019
- Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant.
Neugut Y Dana et al. Annals of internal medicine 2019 Oct - How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL.
Averna Maurizio et al. Atherosclerosis. Supplements 2017 Apr 2616-24 - Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease.
Emanuelsson Frida et al. The Journal of clinical endocrinology and metabolism 2018 103(12) 4491-4500 - Practical considerations for APOL1 genotyping in the living kidney donor evaluation.
Mena-Gutierrez Alejandra M et al. Transplantation 2019 Aug - Novel Machine Learning Approach to Identify Preoperative Risk Factors Associated With Super-Utilization of Medicare Expenditure Following Surgery.
Hyer J Madison et al. JAMA surgery 2019 Aug - Relationship between birth weight and chronic kidney disease: an integrative analysis of observational studies and causal inference through genetic approaches
X Yu et al, BioRXIV preprints, August 8, 2019 - A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypes.
Park Joseph et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Aug - Association of APOL1 Risk Alleles with Cardiovascular Disease in African Americans in the Million Veteran Program.
Bick Alexander G et al. Circulation 2019 Jul - Optimal Use of Biomarkers for Chronic Kidney Disease.
Miller W Greg et al. Clinical chemistry 2019 May - Big data in nephrology: are we ready for the change?
Yang Chao et al. Nephrology (Carlton, Vic.) 2019 Jul
.png)
No hay comentarios:
Publicar un comentario